Cylene Pharmaceuticals cylenepharma.com


Public lists: Pharma Startups (4732)

Cylene Pharmaceuticals is a clinical-stage, private company developing small molecule drugs against newly validated cancer targets. Cylene has taken a position in the discovery and development of first-in-class cancer drugs that activate the p53 tumor suppressor and drugs that target the CK2 protein kinase. The Company's p53 Activator/Pol I program delivered CX-5461, a Phase I stage small molecule that activates p53 to kill cancer cells but not normal ones. Targeting Pol I provides the first pat...Show all

Cylene Pharmaceuticals is a clinical-stage, private company developing small molecule drugs against newly validated cancer targets. Cylene has taken a position in the discovery and development of first-in-class cancer drugs that activate the p53 tumo...Show all

Company (Alive / Active)

Phone: 858-875-5100

Fax: (858) 875-5101

5820 Nancy Ridge Drive
Suite 200
San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cylene Pharmaceuticals $68.9M Sep 28, 2010
Kanisa Pharmaceuticals $25M Dec 13, 2004
Message Pharmaceuticals $12.5M Oct 1, 2001
See all 21 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cylene Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 19 investors

Competitors

Company Status Description Investors
See all 21 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Protein kinase modulators Mar 02, 2009 May 01, 2012 Patent
Oxindole compounds Jun 30, 2009 Feb 28, 2012 Patent
Fused tricyclic compounds as serine-threonine protein kinase and parp modulators Aug 31, 2007 Jun 07, 2011 Patent
Quinolone analogs and methods related thereto Oct 03, 2008 Apr 19, 2011 Patent
Therapeutic kinase modulators Aug 29, 2008 Mar 22, 2011 Patent
See all 6 patents